Lazzaro Alessandro, Colorado Angela Sofia Burkhart, Neff Charles Preston, Nusbacher Nichole, Boyd Kathryn, Fiorillo Suzanne, Martin Casey, Siebert Janet, Campbell Thomas, Borok Margaret, Palmer Brent, Lozupone Catherine
Sapienza University of Rome.
University of Colorado Anschutz Medical Campus.
Res Sq. 2023 Aug 31:rs.3.rs-3300723. doi: 10.21203/rs.3.rs-3300723/v1.
The widespread availability of antiretroviral therapy (ART) for people living with HIV (PLWH) has dramatically reduced mortality and improved life expectancy. However, even with suppression of HIV-1 replication, chronic immune activation and elevated inflammation persist. Chronic immune activation has been linked to a pro-inflammatory gut microbiome composition, exacerbated by compromised intestinal barrier integrity that occurs after HIV infection. Individuals living in urban versus rural areas of sub-Saharan Africa have differences in environmental factors such as water source or diet that may impact gut microbiome composition, yet immune phenotype and gut microbiome composition response to ART in PLWH living in rural versus urban areas of sub-Saharan Africa have not been compared. Here, we measured immune phenotypes and fecal microbiome composition in PLWH and healthy participants recruited from the urban Mabvuku polyclinic in the city of Harare, Zimbabwe and the Mutoko District hospital located in a district 146 km from Harare that services surrounding rural villages. PLWH were either ART naïve at baseline and sampled again after 24 weeks of treatment with efavirenz/lamivudine/tenofovir disoproxil fumarate (EFV/3TC/TDF) and the prophylactic antibiotic cotrimoxazole or were ART experienced at both timepoints. Although expected reductions in the inflammatory marker IL-6, T-cell activation, and exhaustion were observed in individuals who had suppressed HIV-1 with treatment, these changes were significant only when considering individuals in the urban and not the rural area. Gut microbiome composition showed more marked differences from healthy controls in the ART experienced compared to ART naïve cohort, and consistent longitudinal changes were also observed in ART naïve PLWH after 24 weeks of treatment, including a reduction in alpha diversity and altered composition. However, gut microbiome composition showed a more pronounced relationship with chronic immune activation and exhaustion phenotypes in the ART naïve compared to ART experienced PLWH, suggesting a particularly significant role for the gut microbiome in disease progression in uncontrolled infection.
抗逆转录病毒疗法(ART)在人类免疫缺陷病毒(HIV)感染者(PLWH)中的广泛应用显著降低了死亡率并提高了预期寿命。然而,即使HIV-1复制受到抑制,慢性免疫激活和炎症加剧的情况仍然存在。慢性免疫激活与促炎性肠道微生物群组成有关,HIV感染后肠道屏障完整性受损会加剧这种情况。生活在撒哈拉以南非洲城市和农村地区的个体在水源或饮食等环境因素上存在差异,这些因素可能会影响肠道微生物群组成,但尚未对撒哈拉以南非洲城市和农村地区PLWH的免疫表型和肠道微生物群组成对ART的反应进行比较。在这里,我们测量了从津巴布韦哈拉雷市的城市马布武库综合诊所和距离哈拉雷146公里、为周边农村村庄服务的穆托科地区医院招募的PLWH和健康参与者的免疫表型和粪便微生物群组成。PLWH在基线时未接受过ART治疗,在接受依非韦伦/拉米夫定/替诺福韦酯(EFV/3TC/TDF)和预防性抗生素复方新诺明治疗24周后再次进行采样,或者在两个时间点都接受过ART治疗。尽管在接受治疗后HIV-1得到抑制的个体中观察到炎症标志物IL-6、T细胞激活和耗竭的预期降低,但这些变化仅在考虑城市个体而非农村个体时才具有统计学意义。与未接受过ART治疗的队列相比,接受过ART治疗的个体的肠道微生物群组成与健康对照的差异更为明显,并且在未接受过ART治疗的PLWH治疗24周后也观察到了一致的纵向变化,包括α多样性降低和组成改变。然而,与接受过ART治疗的PLWH相比,未接受过ART治疗的PLWH的肠道微生物群组成与慢性免疫激活和耗竭表型的关系更为显著,这表明肠道微生物群在未控制感染的疾病进展中具有特别重要的作用。